Dual role of polymorphonuclear neutrophils on the growth of Ehrlich ascites tumor (EAT) in mice

Life Sciences

Volumn 75, Issue 2, 2004, Pages 245-255

  Bergami Santos, Patrícia C ^a   Mariano, Mário ^b   Barbuto, José Alexandre M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antigranulocyte antibody RB6 8C5; Ehrlich Ascites Tumor; Inflammation; PMN; Polymorphonuclear cells

Indexed keywords

HYDROGEN PEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CANCER RESISTANCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL FUNCTION; CONTROLLED STUDY; CYTOTOXICITY; DATA ANALYSIS; EHRLICH ASCITES TUMOR; INFLAMMATION; INOCULATION; MALE; MOUSE; MOUSE STRAIN; NEUTROPHIL; NONHUMAN; STATISTICAL SIGNIFICANCE; TUMOR GROWTH;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; BODY WEIGHT; CARCINOMA, EHRLICH TUMOR; CYTOTOXICITY, IMMUNOLOGIC; GLYCOGEN; HYDROGEN PEROXIDE; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEUTROPHILS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

ANIMALIA;

EID: 2142810121     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.02.003     Document Type: Article

References (24)

1. Carlomagno C., Perrone F., Lauria R., De Laurentis M., Gallo C., Morabito A., Pettinato G., Panico G., Ballelli T., Apicella A., Petrella G., Bianco A.R., De Placido S. Prognostic significance of necrosis, elastosis, fibrosis, and inflammatory cell resection in operable breast cancer. Oncology. 52:1995;272-277
2. Chen L., Watkins J.F. Evidence against the presence of H2 histocompatibility antigens in Ehrlich ascites tumour cells. Nature. 225:1970;734-735
3. Fecchio D., Russo M., Sirois P., Braquet P., Jancar S. Inhibition of Ehrlich Ascites Tumor in vivo by PAF antagonists. International Journal of Immunopharmacology. 12:1990;57-65
4. Fecchio D., Sirois P., Russo M., Jancar S. Studies on inflammatory response induced by Ehrlich tumor in mice peritoneal cavity. Inflammation. 14:1990;125-131
5. Gil J., Alvarez R., Viñuela J.E., Morales J.G.R., de Bustos A., De La Concha E.G., Subiza J.L. Inhibition of in vivo tumor growth by a monoclonal IgM antibody recognizing tumor cell surface carbohydrates. Cancer Research. 50:1990;7301-7306
6. Ioachim H.L. Correlation between tumor antigenicity, malignant potential and local host immune response. Contemporary Topics in Immunobiology. 10:1980;213-238
7. Mantovani A., Bottazzi B., Colotta F., Sozzani S., Ruco L. The origin and function of tumor-associated macrophages. Immunology Today. 13:1992;265-270
8. Maria D.A., Ribeiro O.G., Pizzocaro K.F., De Franco M., Cabrera W.K., Starobinas N., Gallois V., Siqueira M., Seman M., Ibanez O.M. Resistance to melanoma metastases in mice selected for high acute inflammatory response. Carcinogenesis. 22:2001;337-342
9. Marley S.B., Hadley C.L., Wakelin D. Effect of genetic variation on induced neutrophilia in mice. Infection and Immunity. 62:1994;4304-4309
10. Morales A., Eidinger D., Bruce A.W. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. Journal of Urology. 116:1976;180-183
11. Pattard J.J., Muscatelli-Groux B., Saint F., Popov Z., Maille P., Abbou C., Chopin D. Evaluation of local immune response after intravesical bacille Calmette-Guérin treatment for superficial bladder cancer. British Journal of Urology. 78:1996;709-714
12. Pekarek L.A., Starr B.A., Toledano A.Y., Schreiber H. Inhibition of tumor growth by elimination of granulocytes. Journal of Experimental Medicine. 181:1995;435-440
13. Pick E., Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produce by cells in culture. Journal of Immunological Methods. 38:1980;161-170
14. Pick E., Mizel D. Rapid microassays for the measurement of superoxide and hydrogen production by macrophages in culture using an automatic enzyme immunoassay reader. Journal of Immunological Methods. 46:1981;211-226
15. Punt C.J., Barbuto J.A.M., Zhang H., Grimes W.J., Hatch K.D., Hersh E.M. Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes. Cancer Immunology and Immunotherapy. 38:1994;225-232
16. Rabinovitch M., Manejias R.E., Russo M., Abbey E.E. Increased spreading of macrophages from mice treated with interferon inducers. Cellular Immunology. 29:1977;86-95
17. Ratliff T. Role of the immune response in BCG treatment for bladder cancer. European Urology. 21(Suppl. 2):1992;17-21
18. Ribeiro-Dias F., Barbuto J.A.M., Tsujita M., Jancar S. Discrimination between NK and LAK cytotoxic activities of murine spleen cells by MTT assay. Differential inhibition by PGE2 and EDTA. Journal of Immunological Methods. 241:2000;121-129
19. 0) breast carcinoma: A study of 644 patients with median follow-up of 18 years. Journal of Clinical Oncology. 7:1989;1239-1251
20. Russo M., Teixeira H.C., Marcondes M.C.G., Barbuto J.A.M. Superoxide independent hydrogen peroxide release by activated macrophages. Brazilian Journal of Medical and Biological Research. 22:1989;1271-1273
21. Sigiura K. Tumor transplantation. Gray W.I. Methods of animal experimentation. 1965;171-222 Academic Press, New York
22. Underwood J.C.E. Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review. British Journal of Cancer. 30:1974;538-548
23. van Ravenswaay Claasen H.H., Kluin P.M., Fleuren G.J. Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. Laboratory Investigation. 67:1992;166-174
24. Wong C.K., Fung K.P., Kong S.K., Lee C.Y., Choy Y.M. Endogenous production of tumor necrosis factor in combination with hyperthermia for the treatment of mice bearing Ehrlich ascites tumor. Chemotherapy. 41:1995;378-383